We are proud to share that Dr. Witali Aswolinskiy, AI Lead at PAICON, delivered a talk at the European Symposium on Tumors with Microsatellite Instability (MSI) - Heidelberg 2025 Edition.
Witali spoke during the Startup Sponsor Session on September 18, 2025, presenting his work on: “Uncertainty-Aware Prediction of Microsatellite Instability in Colorectal Cancer from H&E Whole Slide Images”
Advancing AI in Cancer Diagnostics
With a strong background in computational pathology, deep learning, and biomarker prediction, Witali has dedicated his career to advancing the role of AI in oncology. At PAICON, he leads the development of models that transform diverse and complex cancer data into trustworthy AI-driven diagnostics, enabling more precise and inclusive patient care worldwide.
During his presentation, Witali highlighted how uncertainty-aware AI methods can significantly improve the detection of microsatellite instability (MSI) in colorectal cancer, offering a pathway toward more reliable and transparent AI-assisted diagnostics in precision oncology.
A Key Platform for MSI Research
The MSI Symposium Heidelberg 2025, jointly organized by Heidelberg University Hospital and Sorbonne University (AP-HP), provided an international platform for clinicians, scientists, and innovators to exchange insights on the latest advances in MSI diagnostics and therapies across tumor types.
